further Emedastine Overview Side Effects Dosage Professional Pregnancy More Breastfeeding Warnings User Reviews Support Group Q & A Pronunciation (em e DAS teen) Index Terms Emedastine Difumarate Dosage Forms Excipient information presented when available (limited, particularly for generics); consult specific product labeling. Solution, Ophthalmic, as difumarate: Emadine: 0.05% (5 mL) [contains benzalkonium chloride] Slideshow Red, Irritated, Watering Eyes? Chances Are You ve Got Pink Eye Brand Names: U.S. Emadine Pharmacologic Category Histamine H 1 Antagonist Histamine H 1 Antagonist, Second Generation Pharmacology Selective histamine H 1 -receptor antagonist for topical ophthalmic use Absorption Ocular: Minimal Half-Life Elimination Oral: Plasma: 3 to 4 hours Use: Labeled Indications Allergic conjunctivitis: For the temporary relief of the signs and symptoms of allergic conjunctivitis Contraindications Hypersensitivity to emedastine or any component of the formulation Dosing: Adult Allergic conjunctivitis: Ophthalmic: Instill 1 drop in affected eye up to 4 times daily Dosing: Geriatric Refer to adult dosing. Dosing: Pediatric Allergic conjunctivitis: Children 3 years and Adolescents: Refer to adult dosing. Dosing: Renal Impairment There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption. Dosing: Hepatic Impairment There are no dosage adjustments provided in the manufacturer's labeling. However, dosage adjustment unlikely due to low systemic absorption. Administration Ophthalmic: For topical ophthalmic use only, not for injection. Wash hands before use. To avoid contamination, do not touch dropper tip to eyelids or other surfaces when placing drops in eyes. Remove contact lenses prior to administration. Wait 10 minutes before reinserting lenses. Do not wear contact lenses if eyes are red. Storage Store at 4 C to 30 C (39 F to 86 F). Drug Interactions There are no known significant interactions. Adverse Reactions Frequency not always defined. >10%: Central nervous system: Headache (11%) 1% to 10%: Cardiovascular: Hyperemia Central nervous system: Abnormal dreams Dermatologic: Dermatitis, pruritus Gastrointestinal: Dysgeusia Neuromuscular & skeletal: Weakness Ophthalmic: Blurred vision, corneal infiltrates, corneal staining, keratitis, lacrimation, transient burning or stinging in the eyes, xerophthalmia Respiratory: Rhinitis, sinusitis Warnings/Precautions Special populations: Contact lens wearers: Contains benzalkonium chloride which may be absorbed by soft contact lenses; remove contact lenses prior to use and wait 10 minutes before reinserting. Other warnings/precautions: Appropriate use: For topical ophthalmic use only. Do not wear contact lens if eye is red; not for the treatment of contact lens irritation. To avoid contamination, do not touch dropper tip to eyelids or other surfaces when placing drops in eyes. Pregnancy Risk Factor B Pregnancy Considerations Adverse events have not been observed in animal reproduction studies. Systemic absorption is limited following ocular administration. Use during pregnancy is not expected to result in significant exposure to the fetus. Patient Education Discuss specific use of drug and side effects with patient as it relates to treatment. (HCAHPS: During this hospital stay, were you given any medicine that you had not taken before? Before giving you any new medicine, how often did hospital staff tell you what the medicine was for? How often did hospital staff describe possible side effects in a way you could understand?) Patient may experience headache. Have patient report immediately to prescriber vision changes, eye pain, or severe eye irritation (HCAHPS). Educate patient about signs of a significant reaction (eg, wheezing; chest tightness; fever; itching; bad cough; blue skin color; seizures; or swelling of face, lips, tongue, or throat). Note: This is not a comprehensive list of all side effects. Patient should consult prescriber for additional questions. Intended Use and Disclaimer: Should not be printed and given to patients. This information is intended to serve as a concise initial reference for health care professionals to use when discussing medications with a patient. You must ultimately rely on your own discretion, experience, and judgment in diagnosing, treating, and advising patients. Next Pregnancy Warnings Print this page Add to My Med List More about emedastine ophthalmic Side Effects During Pregnancy or Breastfeeding Dosage Information Support Group En Español 0 Reviews Add your own review/rating Drug class: ophthalmic antihistamines and decongestants Consumer resources Emedastine ophthalmic Emedastine Emedastine Ophthalmic (Advanced Reading) Professional resources Emedastine Difumarate (AHFS Monograph) Other brands: Emadine Related treatment guides Conjunctivitis, Allergic Drug Status Rx Availability Prescription only B Pregnancy Category No proven risk in humans N/A CSA Schedule Not a controlled drug Approval History Drug history at FDA Emedastine ophthalmic Rating No Reviews - Be the first! No Reviews - Be the first! Not Rated - Be the first! Drug Class Ophthalmic antihistamines and decongestants Related Drugs ophthalmic antihistamines and decongestants azelastine ophthalmic , Pataday , Patanol , phenylephrine ophthalmic , olopatadine ophthalmic , Zaditor Conjunctivitis, Allergic prednisone , prednisolone ophthalmic , azelastine ophthalmic , Deltasone , Zaditor , cromolyn ophthalmic , doxylamine , Optivar , Alaway , ketotifen ophthalmic , Bepreve , Lastacaft , Sterapred , triprolidine , bepotastine ophthalmic , carbinoxamine , alcaftadine ophthalmic , Equate Sleep Aid , Carboxine , Elestat , epinastine ophthalmic , Prednicot , Livostin , More... prone to
critically Emedastine the truth
EmoticonEmoticon